
Coley's Toxins and the Origins of Immunotherapy
William B. Coley started using a bacterial infection to treat cancers in the late 19th century, one of the earliest uses of immunotherapy. Research: Ahuja, Sana and Sufian Zaheer. “The evolution of cancer immunotherapy: a comprehensive review of its history and current perspectives.” Korean Journal of Clinical Oncology 2024; 20(2): 51-73. DOI: https://doi.org/10.14216/kjco.24009 Atkins, Douglas. “Helen Coley Nauts: Advocate for Immunotherapy.” National Library of Medicine. 4/19/2016. https://circulatingnow.nlm.nih.gov/2016/04/19/helen-coley-nauts-advocate-for-immunotherapy/ Cancer Research Institute. “The History of Cancer Immunotherapy.” Coley, William B. “Therapeutic Value of the Mixed Toxins of the Streptococcus of Erysipelas and Bacillus Prodigiosus in the Treatment of Inoperable Malignant Tumors. With a Report of 160 Cases.” American Journal of the Medical Sciences. September 1896. College of Physicians of Philadelphia. “Cancer Vaccines and Immunotherapy.” History of Vaccines. https://historyofvaccines.org/vaccines-101/future-immunization/cancer-vaccines-and-immunotherapy/ Colley, William B. “The Treatment of Inoperable Sarcoma by Bacterial Toxins (the Mixed Toxins of the Streptococcus erysipelas and the Bacillus prodigiosus).” Reprinted from the “ Proceedings of the Royal Society of Medicine,” November, 1909. London. John Bale, Sons & Danielsson, LTD. 1909.
Publisher
Stuff You Missed in History Class
Link
omny.fm/shows/stuff-you-missed-in-history-class/coleys-toxins-and-the-origins-of-immunotherapy
Published
September 16, 2026
Duration
38 min
Format
Podcast
Category
Issues · History
Catalog
1000 episodes on The Nile
Host
iHeartPodcasts
Stuff You Missed in History Class
@fitandfabulousatfort
#coleystoxins #origins #immunotherapy
